Delivery Order SPE2DB25D7068-SPE2DB25FTWPZ

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,769.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565804930 INFANRIX DTAP SYRINGE 0.5ML, with a completion date of September 16, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,949.00 firm-fixed-price delivery order contract covers the supply of INFANRIX DTAP SYRINGE 0.5ML medical products. The contract has an ultimate completion date of August 21, 2024. While the original solicitation was not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP vaccine syringes. The contract has a ceiling value of $1,363.72 and a period of performance through January 28, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of INFANRIX DTAP SYRINGE 0.5ML. The contract has a ceiling value of $2,034.72 and is a Firm Fixed Price Delivery Order with a completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a $2,064.30 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The delivery order has an ultimate completion date of August 2, 2024 and is a firm-fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INFANRIX DTAP SYRINGE 0.5ML vaccines. This $1,204.90 contract has a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor for this order, which is a child contract under a potential $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA to supply...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product. The contract has a firm fixed price of $2,115.27 and a period of performance through September 26, 2024. It is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, identified as SPE2DB22D1106|SPE2DB25FEKR4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,864.50 firm fixed-price delivery order is for the supply of 4,568,039,738 units of the INFANRIX DTAP SYRINGE 0.5ML vaccine product. The contract has an ultimate completion date of April 28, 2025 and does not include a set-aside designation, indicating open...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation, is for the provision of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,243.25, has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,825.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2022, with a completion date of May 9, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
  • SPE2DB25D7068
    Indefinite Delivery Contract
  • SPE2DB25D7068-SPE2DB25FTWPZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.22 firm fixed-price delivery order is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/8/25, 9:55 AM